Mark Howarth is the Professor of Protein Nanotechnology in Oxford University Department of Biochemistry, where he has been a PI since 2007. In 2017 he co-founded the company SpyBiotech and was awarded the Royal Society of Chemistry Norman Heatley Award. He did postdoctoral studies at MIT with Alice Ting, where he developed monovalent streptavidin and single molecule probes for tracking neurotransmitter receptors. His doctoral work was with Tim Elliott at Southampton University on MHC class I-peptide quality control. His current work is on innovating ultra-stable protein interactions through engineering of bacterial peptide superglues. These tools are being applied to vaccine development, enzyme stabilization, and multimerization of antibody-like molecules for cancer detection and killing.